Together we shape the future of HPB

Innovation to transform HPB outcomes

Challenges of managing symptomatic pancreatic pseudocysts

Picture of patient holding stomach in pain​

Approximately 5% to 16% of patients with acute pancreatitis and 20% to 40% of patients with chronic pancreatitis will develop pancreatic pseudocysts (PP).1 While some patients are asymptomatic, others experience severe pain, bloating and poor digestion and must receive treatment.​

​Symptomatic pancreatic pseudocysts may be treated surgically, percutaneously, or endoscopically. However, surgery is associated with high rates of morbidity (7%-37%) and mortality (6%). Percutaneous drainage also provides limited treatment benefit as recurrence rates are high and fistulas may form.2​

​Purpose-built pseudocyst drainage tools can help healthcare professionals provide cost-effective therapies to improve patient health outcomes. Previously, endoscopic management of pancreatic pseudocysts has been difficult as the available technologies were not designed or intended for this purpose.​

Enabling effcient and effective treatment procedures​

At Boston Scientific, we work tirelessly to deliver innovative solutions that help you offer the best possible treatment experience to your patients.

Pancreatic Fluid  Collection/Walled off necrosis drainage

The AXIOS™ System is intended to overcome the limitations of other drainage options.​

hot axios stent

Connect with us:


1. Aghdassi et al, “Pancreatic pseudocysts – when and how to treat?” HPB 2006; 8: 432-441.​

2. Shah et al, “Safety and Efficacy of Endoscopic Ultrasound-Guided Drainage of Pancreatic Fluid Collections with Lumen-Apposing Covered Self-Expanding Metal Stents.” Gastroenterol and Hepatol Oct 5, 2014; 13: 747-752.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.​​All images owned by Boston Scientific.​